Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Robert F. Newton who wrote (19492)	6/27/1998 5:30:00 PM
From: Bill Wexler	Respond to of 31646

<<People would give you more credit if you had some substance on why you are short on issues>> I have already explained why. The company is financially unsound and the stock is being massively diluted due to the floating of an floorless convertible. This is Fact and can be easily verified by simply reading the past 10-Qs. <<This is not a fly by night operation but has been built by various acquisitions over the past few years. >> Funny that such a powerhouse couldn't get a normal bank loan. Why not? <<Your constant blabbing of scam, hype, fraud is getting old>> Perhaps. But it is so often correct. BTW, I have never claimed that TAVA is a fraud, all I said was that I suspected a stock promotion scheme. <<The bottom line is TAVA will be made or broken based on earnings>> In that case...look out below!! <<Your past record - Just remember a stopped clock is right twice per day.>> Why is it stopped? Does it have one of those "embedded systems" Y2K problems?

To: Robert F. Newton who wrote (19492)	6/27/1998 5:48:00 PM
From: Phillip Kelly	Respond to of 31646

A little mention from WSJ on 6/22 re: CMED's potential earnings. John Vareka, research analyst at John G. Kinnard & Co., in Denver, has a 12-month target of 15 for the stock. Vareka said he thinks there's "some upside potential" in an agreement that lets Colorado MEDtech use software developed by another Denver-area company, Tava Technologies Inc., in a new product designed to eliminate Year 2000 bugs from biomedical devices in health-care facilities.